Spectral taps NASA scientist to join team
Spectral Molecular Imaging, a wholly owned subsidiary of Cascade Technologies, has appointed Gregory Bearman, PhD, to the position of chief scientist, where he will guide development of imaging devices for the detection of cancer and other diseases, based on the company's optical imaging technologies.
Trained in atomic physics, Bearman worked for nearly 30 years (1979-2008) at NASA's Jet Propulsion Laboratory in Pasadena, Calif., where he was a principal scientist, managing a group that developed technologies and instruments for remote sensing and planetary surface exploration, with an emphasis on developing new sensors and spectral imagers, according to the Beverly Hills, Calif.-based Spectral.
He has been a visiting scientist at St. Luke's Hospital in Houston and Cedars-Sinai Medical Center in Los Angeles, and has an adjunct appointment in the ophthalmology department at the USC Keck School of Medicine in Los Angeles, Spectral reported. He is a member of the editorial board of the Journal of Biomedical Optics.
Trained in atomic physics, Bearman worked for nearly 30 years (1979-2008) at NASA's Jet Propulsion Laboratory in Pasadena, Calif., where he was a principal scientist, managing a group that developed technologies and instruments for remote sensing and planetary surface exploration, with an emphasis on developing new sensors and spectral imagers, according to the Beverly Hills, Calif.-based Spectral.
He has been a visiting scientist at St. Luke's Hospital in Houston and Cedars-Sinai Medical Center in Los Angeles, and has an adjunct appointment in the ophthalmology department at the USC Keck School of Medicine in Los Angeles, Spectral reported. He is a member of the editorial board of the Journal of Biomedical Optics.